ストックスクリーナーアプリを入手
129.59
1.88%
2.53
Morgan Stanley (MS) 最新ニュース
XP, B3 stocks rise after Morgan Stanley upgrades to Overweight on lower interest rates (XP:NASDAQ) - Seeking Alpha
Morgan Stanley maintains Sarepta stock with $113 target - Investing.com
Medical Technology Firms Face Price Target Revisions From Morgan Stanley - marketscreener.com
Target Likely to Report Weak Q1, Outlook, Morgan Stanley Says - marketscreener.com
Robinhood EPS Estimates Raised on Equity, Option Revenue Gains, Morgan Stanley Says - marketscreener.com
Morgan Stanley Ejects Broker on Billion-Dollar Houston Team Over Real Estate Deal - AdvisorHub
Form 424B2 MORGAN STANLEY - StreetInsider
Morgan Stanley on Sarepta (SRPT): 'Elevidys Approval in Japan Further Confirms Favorable Benefit/Risk Profile' - StreetInsider
Keysight Techs (KEYS) Price Target Raised by Morgan Stanley | KE - GuruFocus
Charles Schwab (SCHW) Price Target Raised by Morgan Stanley | SC - GuruFocus
Too soon to see impact of tariffs: Morgan Stanley - BNN Bloomberg
Fox (FOXA) Price Target Raised by Morgan Stanley | FOXA Stock Ne - GuruFocus
Rapid7 (RPD) Price Target Boosted by Morgan Stanley on Strategic Value | RPD Stock News - GuruFocus
Integral Ad Science (IAS) Sees Price Target Adjustment by Morgan Stanley | IAS Stock News - GuruFocus
i3 Verticals (IIIV) Target Price Adjustment by Morgan Stanley | - GuruFocus
Morgan Stanley Adjusts Price Target and Forecasts for IFF | IFF Stock News - GuruFocus
Morgan Stanley Sticks to Buy Rating on Cisco Stock (CSCO) Ahead of Earnings - Yahoo Finance
Morgan Stanley maintains UNH stock with $563 target post-CEO change - Investing.com
Morgan Stanley Adjusts Price Target on TransMedics Group to $103 From $80, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Integra LifeSciences Holdings to $10 From $20, Maintains Equalweight Rating - marketscreener.com
Tariff Truce Presents Opportunities in US and China, Says Morgan Stanley - Bloomberg
Morgan Stanley Adjusts Price Target on Globus Medical to $75 From $100, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Embecta to $15 From $20, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Cuts Price Target on Treace Medical Concepts to $8 From $10, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley maintains Target stock Overweight with $160 target - Investing.com
4,795 Shares in Morgan Stanley (NYSE:MS) Acquired by Investor s Fiduciary Advisor Network LLC - MarketBeat
Morgan Stanley Digital Assets Head Quits to Start New DeFi Fund - Bloomberg Government News
Morgan Stanley Adjusts Price Target on RxSight to $20 From $42, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Rapid7 to $28 From $26, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Robinhood Markets to $43 From $40, Maintains Equalweight Rating - marketscreener.com
Charles Schwab (SCHW) Price Target Boosted by Morgan Stanley | S - GuruFocus
Morgan Stanley Reiterates Overweight Rating on Target (TGT), PT $160 - StreetInsider
Janus Henderson Group PLC Trims Stock Holdings in Morgan Stanley (NYSE:MS) - MarketBeat
Airbnb (ABNB) Faces Price Target Cut by Morgan Stanley | ABNB St - GuruFocus
Morgan Stanley Upgrades XP to Overweight From Equalweight, Adjusts Price Target to $24 From $18 - marketscreener.com
Morgan Stanley Downgrades Nextdoor Holdings to Underweight From Equalweight - marketscreener.com
Morgan Stanley Updates Price Target for i3 Verticals (IIIV) | II - GuruFocus
Morgan Stanley Just Touted A $5 TRILLION Opportunity For Tesla Stock - Barchart.com
Monzo reportedly gears up for a potential GBP 6 billion IPO - The Paypers
Morgan Stanley lifts XP Inc. stock rating, raises target to $24 - Investing.com India
“Don’t Miss Out on Nvidia’s (NVDA) Growth Ahead,” says Top Morgan Stanley Analyst - TipRanks
Morgan Stanley Adjusts Price Target on Airbnb to $125 From $130, Maintains Underweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on International Flavors & Fragrances to $98 From $100, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Keysight Technologies to $180 From $156, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Insulet to $355 From $325, Maintains Overweight Rating - marketscreener.com
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Has $3.65 Million Stock Holdings in Morgan Stanley (NYSE:MS) - MarketBeat
Morgan Stanley Adjusts PT on Charles Schwab to $83 From $76, Maintains Overweight Rating - marketscreener.com
Morgan Stanley cuts IONOS stock rating to Equalweight, target to EUR38 - Investing.com
Morgan Stanley to manage Banco de Sabadell security stabilization - Investing.com
Tesla Supplier CATL Sets Modest Underwriting Fees For World's Biggest IPO Of 2025 - Benzinga
Figma hires Morgan Stanley as lead for upcoming IPO - Tech in Asia
U.S. stocks are no longer "leading the way"! Morgan Stanley warns: three driving factors are weakening - longportapp.com
Morgan Stanley Earns Relative Strength Rating Upgrade; Hits Key Benchmark - Investor's Business Daily
Hindustan Petroleum Is Morgan Stanleys Top Pick Among Oil Retailers — Heres Why - NDTV Profit
XP Inc. (XP) Receives Upgrade from Morgan Stanley with Increased Price Target | XP Stock News - GuruFocus
Morgan Stanley Is Leading IPO for Software Maker Figma - Bloomberg
Morgan Stanley rates DNL as Equal-weight - marketscreener.com
U.S.-China Trade Truce: What’s Next? - Morgan Stanley
UTI Prepares for New Offering with Morgan Stanley's Support | UT - GuruFocus
Morgan Stanley cuts Nextdoor stock rating, price target to $1.10 By Investing.com - Investing.com India
JPMorganChase to Present at the Morgan Stanley U.S. Financials C - GuruFocus
Rep. Jefferson Shreve Sells Morgan Stanley (NYSE:MS) Shares - MarketBeat
Morgan Stanley at Work Liquidity Trends Report - Morgan Stanley
JPMorganChase to Present at the Morgan Stanley U.S. Financials Conference - marketscreener.com
Morgan Stanley cuts Nextdoor stock rating, price target to $1.10 - Investing.com
Nvidia in focus as Morgan Stanley says April Taiwan data shows 'significant improvements' - MSN
Himax Technologies (HIMX): Morgan Stanley Backs AI Expansion with ‘Overweight’ Rating - Insider Monkey
Morgan Stanley Direct Lending Fund Prices Public Offering of $350.0 Million 6.000% Notes Due 2030 - Stock Titan
Morgan Stanley cuts Akero stock price target to $84 from $90 - Investing.com India
Diageo (DEO) Faces Price Target Cut by Morgan Stanley Analyst | - GuruFocus
Novo Nordisk (NVO) Sees Price Target Cut by Morgan Stanley Analy - GuruFocus
Akero Therapeutics (AKRO) Price Target Lowered by Morgan Stanley | AKRO Stock News - GuruFocus
4.62%
4.01%
大文字化:
|
ボリューム (24 時間):